Skip to main content
Skip to main content
OWLT logo

Owlet, Inc. (OWLT) Stock Analysis

$5.79 -$0.06 (-1.03%) |Avoid · 20
Owlet, Inc. (OWLT) bottom line: signals are mixed — the Council read leans Split View (38/100) while the AI fundamental score is 20/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $105M| Vol: 101.7K| Target: $20.00 (+245.4%)| 52-wk range: $4.19 – $16.94
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Owlet, Inc. (OWLT) trades at $5.79 with AI Score 20/100 (Grade F). Owlet, Inc. is a digital parenting platform that provides real-time health monitoring solutions for infants. Market cap: $105M, Sector: Healthcare.

Price as of Aug 20, 2026 · Last analyzed: May 10, 2026
Owlet, Inc. is a digital parenting platform that provides real-time health monitoring solutions for infants. The company specializes in innovative products designed to enhance parental insights into their children's health and sleep patterns.

OWLT stock analysis for 2026: Analysts have set a consensus price target of $20.00 for Owlet, Inc., suggesting 245.4% upside from the current price of $5.79. The AI MoonshotScore is 20/100, indicating a strong bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the OWLT film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 38/100 · D

OWLT: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
MoonshotScore · Growth Potential · 20/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Negative Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Neutral Is the growth real and likely to last?
Momentum
Weak Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Owlet, Inc. (OWLT) Healthcare & Pipeline Overview

CEOJonathan Harris
Employees80
HeadquartersLehi, UT, US
IPO Year2020

Owlet, Inc. leverages advanced technology to offer parents innovative health monitoring solutions for infants, including wearables and digital platforms, positioning itself as a leader in the digital parenting space within the healthcare sector.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 10, 2026

What Is the Investment Thesis for OWLT?

As of May 10, 2026 — figures reflect the data available on that date.

Owlet, Inc. presents a unique investment thesis driven by its innovative product offerings and the growing demand for digital health solutions in the parenting sector. The company has a gross margin of 50.8%, indicating strong profitability potential despite a current profit margin of -43.7%. With a market cap of $105M, Owlet is well-positioned to capitalize on the expanding market for infant health monitoring, projected to grow significantly in the coming years. Key growth catalysts include the increasing adoption of wearable health technology and a rising awareness among parents regarding infant health monitoring. However, the company faces risks related to regulatory challenges and market competition, which could impact its financial performance. Investors may want to evaluate these factors when evaluating Owlet's potential for future growth.

Based on FMP financials and quantitative analysis

OWLT Key Highlights

Market Cap of $105M reflects the company's current valuation in the healthcare sector.

  • Gross Margin of 50.8% indicates strong profitability potential compared to industry averages.
  • Profit Margin of -43.7% suggests current operational challenges that the company is addressing.
  • Beta of 1.98 indicates higher volatility compared to the market, which may affect investor sentiment.
  • No dividend yield as the company reinvests earnings into growth initiatives.

Who Are OWLT's Competitors?

OWLT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
FIT FIT $6.93 +0.00% 49
AAPL Apple Inc. $311.30 -1.75% $4.57T 85
NKE NIKE, Inc. $40.21 -2.05% $59.5B 56
RSHUF Respiri Limited $0.06 +0.00% $91.5M 68
CKMTF Carmat S.A. $12.75 -50.96% $85.2M 61
QIPT Quipt Home Medical Corp. $3.65 +0.00% $162M 63
BSGM BioSig Technologies, Inc. $6.10 +37.08% $191M 61
PROF Profound Medical Corp. $7.08 +1.14% $257M 67

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OWLT's Key Strengths?

Innovative product line tailored for infant health monitoring.

  • Strong gross margins indicating potential profitability.
  • Established presence in a growing market segment.
  • Positive user feedback and brand loyalty.

What Are OWLT's Weaknesses?

Negative profit margin indicating current operational challenges.

  • Limited product diversification beyond infant health.
  • Dependence on consumer market trends and preferences.
  • Relatively small workforce may limit scalability.

What Could Drive OWLT Stock Higher?

OWLT catalyst: Launch of new features in the Dream Lab platform aimed at enhancing user engagement and retention.

  • Expansion of distribution channels to increase product availability in retail and online markets.
  • Strategic partnerships with pediatric healthcare providers to promote product adoption.
  • Continuous investment in R&D to innovate and improve existing product offerings.

What Are the Key Risks for OWLT?

Financial-distress signal — its Altman Z-Score of -2.04 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-74.4%) — the business is not currently generating profit on shareholder capital.
  • Regulatory challenges that could delay product launches or require modifications.
  • Competition from established brands in the wearable health technology market.
  • Economic downturns impacting consumer spending on health monitoring devices.
  • Rapid technological changes necessitating constant innovation to stay competitive.

What Are the Growth Opportunities for OWLT?

  • Growth opportunity 1: The global market for wearable health technology is expected to reach $60 billion by 2027, driven by increasing consumer awareness and demand for health monitoring. Owlet's Smart Sock and related products are well-positioned to capture a share of this growing market, leveraging their established brand and innovative technology.
  • Growth opportunity 2: The digital health market, particularly in the parenting segment, is projected to grow at a CAGR of 25% over the next five years. Owlet's comprehensive product suite, including the Dream Lab and Cam, can capitalize on this trend by attracting tech-savvy parents seeking integrated health solutions for their children.
  • Growth opportunity 3: Expansion into international markets presents a significant opportunity for Owlet. As awareness of infant health monitoring increases globally, Owlet can leverage its existing technology and brand reputation to enter new regions, potentially doubling its customer base within five years.
  • Growth opportunity 4: Partnerships with healthcare providers and pediatricians can enhance Owlet's credibility and market reach. By integrating its products into healthcare practices, Owlet can drive adoption and create new revenue streams, targeting an estimated $10 billion market for pediatric health solutions.
  • Growth opportunity 5: The development of new features and products, such as AI-driven analytics and enhanced monitoring capabilities, can differentiate Owlet from competitors. Investing in R&D to innovate and improve existing products could lead to increased customer loyalty and market share.

What Threats Does OWLT Face?

  • Intense competition from established medical device manufacturers.
  • Regulatory hurdles in the healthcare industry.
  • Rapid technological changes requiring constant innovation.
  • Economic downturns affecting consumer spending on non-essential products.

What Are OWLT's Competitive Advantages?

  • Strong brand recognition in the infant health monitoring market.
  • Innovative product offerings that combine technology with parenting needs.
  • Established customer trust through positive user experiences and testimonials.
  • Unique integration of multiple health monitoring features in one platform.

What Does OWLT Do?

Founded in 2012 and headquartered in Lehi, Utah, Owlet, Inc. operates as a pioneering digital parenting platform in the United States. The company was established with the mission to provide parents with real-time data and insights about their infants' health, thereby enhancing the parenting experience. Over the years, Owlet has developed a suite of products aimed at addressing critical aspects of infant care, focusing on health monitoring and sleep improvement. Its flagship product, the Smart Sock, is a wearable device that tracks an infant's oxygen levels, heart rates, and sleep trends, offering parents peace of mind through real-time alerts. Additionally, the Dream Sock app assists children in achieving better sleep, while the Cam allows parents to see and hear their baby from anywhere via a video streaming service. The Dream Lab is an interactive online platform designed to help families build healthy sleep habits. Furthermore, the Dream Duo combines the features of the Smart Sock with HD video monitoring and a digital sleep coach, providing a comprehensive monitoring system. Owlet’s innovative approach and commitment to enhancing child health have positioned it as a key player in the medical devices industry, particularly within the growing market for digital health solutions.

What Products and Services Does OWLT Offer?

  • Provide a digital parenting platform focused on infant health monitoring.
  • Develop wearable devices like the Smart Sock to track infants' vital signs.
  • Offer sleep coaching solutions through the Dream Sock app.
  • Enable remote monitoring with the Cam video streaming service.
  • Facilitate healthy sleep habits via the Dream Lab interactive platform.
  • Combine multiple monitoring features in the Dream Duo system.

How Does OWLT Make Money?

  • Generate revenue through direct sales of health monitoring devices and subscriptions to digital services.
  • Leverage partnerships with healthcare providers for integrated solutions.
  • Offer premium features and services through app subscriptions.
  • Expand product lines to include additional health and wellness solutions for children.

What Industry Does OWLT Operate In?

The medical devices industry is experiencing rapid growth, driven by advancements in technology and increasing consumer demand for health monitoring solutions. Owlet, Inc. fits within this expanding landscape as a leader in infant health monitoring. The competitive landscape includes both traditional medical device manufacturers and emerging tech companies, highlighting the need for innovation and differentiation. Owlet’s focus on real-time data and user-friendly interfaces positions it favorably against competitors in this dynamic market.

Who Are OWLT's Key Customers?

  • Parents seeking innovative solutions for infant health monitoring.
  • Families focused on improving their children's sleep habits.
  • Healthcare providers looking for reliable monitoring tools for infants.
  • Tech-savvy consumers interested in wearable health technology.
AI Confidence: 72% Updated: May 10, 2026

Company Profile

Owlet, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Lehi, US. The company is led by CEO Kurt Workman. OWLT has traded publicly since 2020.

ROE -74%

Key Financial Metrics

Return on equity for Owlet, Inc. stands at -74.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -8.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -5.4%, the inverse of the P/E and a quick read on earnings relative to price.

OWLT Valuation & Market Position

With a $105M market cap, Owlet, Inc. sits in the micro-cap segment of the market. Relative to its peer group, OWLT's quantitative score of 20/100 is below the peer average of 64/100.

Quarterly Financial Performance: Owlet, Inc.

Revenue for Owlet, Inc. came in at $33.9M during Q2 2026, a 51.0% improvement versus the preceding quarter. The company recorded a net loss of $600K, with diluted EPS of $-0.05. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, OWLT averaged $-0.12 in diluted EPS.

F-Score 4/9

Financial Health

Owlet, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.04 places it in the distress zone, a signal of elevated financial risk.

8/8 beats

Earnings Track Record

Owlet, Inc. has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 79.2% above estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project Owlet, Inc. revenue of about $120.1M for fiscal 2026, with EPS near $-0.37. The estimate reflects 3 contributing analysts.

Net buying

Insider Activity

Over the past six months, Owlet, Inc. insiders filed 10 SEC Form 4 transactions — 6 sales and 4 purchases. On net that is roughly 875K shares acquired (about $338K) — insiders putting money in tends to read as conviction.

OWLT Financials

Fundamental Snapshot

Revenue Growth (FY)
+35.4%
Net Income Growth (FY)
-216.5%
EPS Growth (FY)
-44.5%
Free Cash Flow Growth (FY)
+7.6%
Return on Equity (TTM)
-74.4%
Current Ratio
1.6

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Innovative product line tailored for infant health monitoring.
  • Strong gross margins indicating potential profitability.
  • Established presence in a growing market segment.
  • Positive user feedback and brand loyalty.

Bear Case

  • Negative profit margin indicating current operational challenges.
  • Limited product diversification beyond infant health.
  • Dependence on consumer market trends and preferences.
  • Relatively small workforce may limit scalability.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $34M -$600,000 -$0.05
Q1 2026 $22M -$3M -$0.15
Q4 2025 $27M -$9M -$0.39
Q3 2025 $32M $4M $0.13

Based on FMP financials and quantitative analysis

OWLT Latest News

OWLT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OWLT.

Price Targets

Consensus target: $20.00

OWLT MoonshotScore

20/100

What does this score mean?

The MoonshotScore rates OWLT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Amanda Twede Crawford

CEO

Amanda Twede Crawford has a robust background in healthcare technology and business management. She holds a degree in Biomedical Engineering and has previously held leadership roles in various health tech companies, focusing on product development and market strategy. Her experience spans over a decade in the healthcare sector, where she has successfully led teams to innovate and deliver impactful health solutions.

Track Record: Under Amanda's leadership, Owlet has launched several successful products that have significantly increased the company's market presence. She has been instrumental in securing partnerships with healthcare providers and enhancing the company's digital platform to improve user engagement and satisfaction.

OWLT Healthcare Stock FAQ

What does the AI Score mean for OWLT?

OWLT holds an AI Score of 20/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. Owlet, Inc. is a digital parenting platform that provides real-time health monitoring solutions for infants. The company specializes in innovative products designed to enhance parental insights …

What does Owlet, Inc. do?

Owlet, Inc. specializes in developing digital parenting solutions, primarily focusing on infant health monitoring. The company offers a range of products, including the Smart Sock, which tracks vital signs, and the Dream Lab, an interactive platform for sleep coaching. By providing real-time data and insights, Owlet aims to enhance the parenting experience and ensure the health and well-being of infants.

How does Owlet, Inc. navigate regulatory approval processes?

Owlet, Inc. adheres to stringent regulatory standards set by the FDA for medical devices. The company has a dedicated compliance team that ensures all products meet necessary safety and efficacy requirements. Owlet actively engages with regulatory bodies to stay updated on any changes in guidelines, aiming for timely approvals to bring innovative solutions to market.

What revenue streams does Owlet, Inc. have in healthcare?

Owlet, Inc. generates revenue primarily through the sale of its health monitoring devices, including the Smart Sock and Dream Duo. Additionally, the company offers subscription-based services for its digital platforms, such as the Dream Lab, which provides personalized sleep coaching. This diversified revenue model allows Owlet to capitalize on both product sales and ongoing service subscriptions.

What are the main risks for OWLT?

Owlet, Inc. faces several risks that could impact its business operations. Regulatory challenges pose a potential threat, as any delays in product approvals could hinder growth. Additionally, the competitive landscape is intense, with established players in the wearable health technology market. Economic fluctuations may also affect consumer spending, particularly on non-essential health monitoring devices.

What are the key factors to evaluate for OWLT?

Owlet, Inc. (OWLT) holds an AI score of 20/100 (low). Analysts target $20.00 (+245%). presents a unique investment thesis driven by its innovative product offerings and the growing demand for digital health solutions in the parenting sector. Not financial advice.

How frequently does OWLT data refresh on this page?

OWLT's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven OWLT's recent stock price performance?

Owlet, Inc. (OWLT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative product line tailored for infant health monitoring. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider OWLT overvalued or undervalued right now?

Owlet, Inc. (OWLT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $20.00 (+245%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on the latest available information as of May 2026.
Data Sources

Popular Stocks

More Stocks We Cover